Interpretation of metaanalyses: Pitfalls should be more widely recognized

Journal of Rheumatology

Volumn 39, Issue 6, 2012, Pages 1107-1109

  Henrotin, Yves E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

ARTHRALGIA; EDITORIAL; EFFECT SIZE; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MEDICAL DECISION MAKING; MEDICAL LITERATURE; META ANALYSIS (TOPIC); OSTEOARTHRITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; TREATMENT RESPONSE; VALIDITY;

ANTIRHEUMATIC AGENTS; CHONDROITIN; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; GLUCOSAMINE; HUMANS; META-ANALYSIS AS TOPIC; OSTEOARTHRITIS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84861821039     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111420     Document Type: Editorial

References (16)

1. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. [Internet. Accessed February 6, 2012.] Available from: www.cochrane-handbook.org
2. Bown MJ, Sutton AJ. Quality control in systematic reviews and meta-analyses. Eur J Vasc Endovasc Surg 2010;40:669-77.
3. Honig PK. Systematic reviews and meta-analyses in the new age of transparency. Clin Pharmcol Ther 2010;88:155-8.
4. Kranke P. Evidence-based practice: How to perform and use systematic reviews for clinical decision making. Eur J Anaesthesiol 2010;27:763-72.
5. Wandel S, Jüni P, Tendal B, Nüesch E, Villiger P, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: Network meta-analysis. BMJ 2010;341:c4675.
6. Glacovelli G, Rovati LC. Conclusions not supported by methods and results. BMJ 2010;341:c6338.
7. Pelletier JP, du Souich P, Kahan A, Michel BA. Effect size is encouraging. BMJ 2010;341:c6328.
8. Reginster JY, Altman RD, Hochberg MC. Prescribed regimen is effective. BMJ 2010;341:c6335.
9. Markenson JA. Review: Glucosamine and chondroitin, alone or in combination, do not clinically improve knee or hip pain in osteoartritis. Ann Intern Med 2011;154:JC3-4.
10. Bruyère O. Large review finds no clinically important effect of glucosamine or chondroitin on pain in people with osteoarthritis of knee and hip but results are questionable and likely due to heterogeneity. Evid Base Med 2011;16:52-3.
11. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part III: Changes in evidence following systematic cumulative update of research published through 2009. Osteoarthritis Cartilage 2010;18:476-99.
12. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55. (Pubitemid 37500619)
13. Chevalier X, Henrotin Y. OARSI recommendations on knee and hip osteoarthritis: Use with discernment. J Bone Spine 2009;76:455-7.
14. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: Meta-analysis of randomised controlled trials. Ann Rheum Dis 2008;67:1716-23.
15. Groves T. Report from BMJ post publication review meeting. [Internet. Accessed February 6, 2012.] Available from: http://www.bmj.com/rapid-response/ 2011/11/03/rereport-bmj-post-publication-review-meeting
16. Henrotin Y. Need for high-standard translation methodology for dissemination of guidelines. Osteoarthritis Cartilage 2009;17:1536-8.